These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3423740)

  • 1. Specific deposition of serum amyloid A protein 2 in the mouse.
    Shiroo M; Kawahara E; Nakanishi I; Migita S
    Scand J Immunol; 1987 Dec; 26(6):709-16. PubMed ID: 3423740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation.
    Meek RL; Hoffman JS; Benditt EP
    J Exp Med; 1986 Mar; 163(3):499-510. PubMed ID: 3950541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation from SAA2-fibrils to AA-fibrils in amyloid fibrillogenesis: in vivo observations in murine spleen using anti-SAA and anti-AA antibodies.
    Arai K; Miura K; Baba S; Shirasawa H
    J Pathol; 1994 Jun; 173(2):127-34. PubMed ID: 8089807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.
    Kawahara E; Shiroo M; Nakanishi I; Migita S
    Am J Pathol; 1989 Jun; 134(6):1305-14. PubMed ID: 2757120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the inbred CE/J mouse strain as amyloid resistant.
    Sipe JD; Carreras I; Gonnerman WA; Cathcart ES; de Beer MC; de Beer FC
    Am J Pathol; 1993 Nov; 143(5):1480-5. PubMed ID: 7901995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of SAA and amyloidogenesis in congenic mice of CE/J and C57BL/6 strains.
    Wang L; Liepnieks JJ; Benson MD; Kluve-Beckerman B
    Amyloid; 2000 Mar; 7(1):26-31. PubMed ID: 10842702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major acute-phase reactant synthesis during chronic inflammation in amyloid-susceptible and -resistant mouse strains.
    Zahedi K; Gonnerman WA; Debeer FC; Debeer MC; Steel DM; Sipe JD; Whitehead AS
    Inflammation; 1991 Feb; 15(1):1-14. PubMed ID: 1711511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
    Liepnieks JJ; Kluve-Beckerman B; Benson MD
    Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
    Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins.
    Yu J; Guo JT; Zhu H; Kindy MS
    Amyloid; 2000 Mar; 7(1):32-40. PubMed ID: 10842703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. apo-SAA1/apo-SAA2 isotype ratios during casein- and amyloid-enhancing-factor-induced secondary amyloidosis in A/J and C57BL/6J mice mice.
    Hébert L; Gervais F
    Scand J Immunol; 1990 Feb; 31(2):167-73. PubMed ID: 2309099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of amyloid in murine and human secondary amyloidosis by the immunoperoxidase technique.
    Livni N; Laufer A; Levo Y
    J Pathol; 1980 Dec; 132(4):343-8. PubMed ID: 7003080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
    Hawkins PN; Myers MJ; Epenetos AA; Caspi D; Pepys MB
    J Exp Med; 1988 Mar; 167(3):903-13. PubMed ID: 3351437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mouse apolipoprotein SAA1.1 in CE/J mice: isoform-specific effects on amyloidogenesis.
    Yu J; Zhu H; Guo JT; de Beer FC; Kindy MS
    Lab Invest; 2000 Dec; 80(12):1797-806. PubMed ID: 11140693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
    Stenstad T; Magnus JH; Husby G
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):663-70. PubMed ID: 7980430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice.
    Watanabe K; Uchida K; Chambers JK; Ushio N; Nakayama H
    Vet Pathol; 2017 Jan; 54(1):99-110. PubMed ID: 27565681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody recognizing apolipoprotein E peptides in systemic amyloid deposits.
    Yamada T; Kakihara T; Gejyo F; Okada M
    Ann Clin Lab Sci; 1994; 24(3):243-9. PubMed ID: 8048796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical identification of amyloid in formalin-fixed paraffin sections.
    Shirahama T; Skinner M; Cohen AS
    Histochemistry; 1981; 72(2):161-71. PubMed ID: 7024214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunolocalization of serum amyloid A and AA amyloid in lysosomes in murine monocytoid cells: confocal and immunogold electron microscopic studies.
    Chronopoulos S; Laird DW; Ali-Khan Z
    J Pathol; 1994 Aug; 173(4):361-9. PubMed ID: 7965395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brefeldin A inhibits experimentally induced AA amyloidosis.
    Stenstad T; Husby G
    J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.